{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:58:39Z","timestamp":1790477919410,"version":"4.1.0"},"reference-count":23,"publisher":"Portland Press Ltd.","issue":"12","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,6,29]]},"abstract":"<jats:p>Data on the consequences of cirrhosis regression on portal hypertension and on splanchnic and systemic hemodynamic are scarce. Previous studies have reported a decrease in hepatic venous pressure gradient following antiviral treatment in patients with hepatitis B or C related cirrhosis. However, these studies did not investigate splanchnic and systemic hemodynamic changes associated with virus control. To fill this gap in knowledge, in a recent issue of Clinical Science, Hsu et al. (vol. 132, issue 6, 669-683) used rat models of cirrhosis induced by thioacetamide and by bile duct ligation and provided a comprehensive analysis of the effects of cirrhosis regression on splanchnic and systemic hemodynamics. They observed a significant reduction in portal pressure accompanied by a normalization of systemic hemodynamic (normal cardiac index and systemic vascular resistance) and a decrease in intrahepatic vascular resistance. No change in extrahepatic vascular structures were observed despite normalization of collateral shunting, meaning that portosystemic collaterals persist but are not perfused. One intriguing part of their results is the only marginal effect of cirrhosis regression on liver hyperarterialisation. This result suggests that changes in splanchnic hemodynamic features induced by cirrhosis remain when hepatic vascular resistance decreases, raising the hypothesis of an autonomous mechanism persisting despite regression of intrahepatic vascular resistance. Microbiota changes and bacterial translocation might account for this effect. In conclusion cirrhosis regression normalizes systemic hemodynamics, but some splanchnic hemodynamic changes persist including extrahepatic angiogenesis and liver hyperarterialization.<\/jats:p>","DOI":"10.1042\/cs20180129","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T13:05:31Z","timestamp":1530191131000},"page":"1341-1343","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cirrhosis regression: extrahepatic angiogenesis and liver hyperarterialization persist"],"prefix":"10.1042","volume":"132","author":[{"given":"Audrey","family":"Payanc\u00e9","sequence":"first","affiliation":[{"name":"DHU Unity, P\u00f4le des Maladies de l\u2019Appareil Digestif, Service d\u2019H\u00e9patologie, Centre de R\u00e9f\u00e9rence des Maladies Vasculaires du Foie, H\u00f4pital Beaujon, AP-HP, Clichy, France"},{"name":"Universit\u00e9 Denis Diderot-Paris 7, Sorbonne Paris Cit\u00e9, 75018 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Emmanuel","family":"Rautou","sequence":"additional","affiliation":[{"name":"DHU Unity, P\u00f4le des Maladies de l\u2019Appareil Digestif, Service d\u2019H\u00e9patologie, Centre de R\u00e9f\u00e9rence des Maladies Vasculaires du Foie, H\u00f4pital Beaujon, AP-HP, Clichy, France"},{"name":"Universit\u00e9 Denis Diderot-Paris 7, Sorbonne Paris Cit\u00e9, 75018 Paris, France"},{"name":"Inserm, U970, Paris Cardiovascular Research Center - PARCC, 56 rue Leblanc 75015 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2018,6,28]]},"reference":[{"key":"2021113011020628000_B1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1042\/CS20171370","article-title":"Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution","volume":"132","author":"Hsu","year":"2018","journal-title":"Clin. Sci."},{"key":"2021113011020628000_B2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/liv.12576","article-title":"Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis","volume":"35","author":"Akhtar","year":"2015","journal-title":"Liver Int."},{"key":"2021113011020628000_B3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1053\/gast.2003.50013","article-title":"Histological outcome during long-term lamivudine therapy","volume":"124","author":"Dienstag","year":"2003","journal-title":"Gastroenterology"},{"key":"2021113011020628000_B4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5 year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet North Am. Ed."},{"key":"2021113011020628000_B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-018-2340-2","article-title":"Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.","author":"Hytiroglou","year":"2018","journal-title":"Virchows Arch."},{"key":"2021113011020628000_B6","doi-asserted-by":"publisher","first-page":"1273.e1","DOI":"10.1053\/j.gastro.2017.07.016","article-title":"Effects of all-oral antiviral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis","volume":"153","author":"Lens","year":"2017","journal-title":"Gastroenterology"},{"key":"2021113011020628000_B7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","article-title":"Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension","volume":"65","author":"Mandorfer","year":"2016","journal-title":"J. Hepatol."},{"key":"2021113011020628000_B8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29557","article-title":"Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C","author":"Mauro","year":"2017","journal-title":"Hepatology"},{"key":"2021113011020628000_B9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jhep.2009.05.031","article-title":"Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension","volume":"51","author":"Manolakopoulos","year":"2009","journal-title":"J. Hepatol."},{"key":"2021113011020628000_B10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/hep.1840170202","article-title":"Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients","volume":"17","author":"Hadengue","year":"1993","journal-title":"Hepatology"},{"key":"2021113011020628000_B11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.1840160316","article-title":"Hemodynamics during liver transplantation: the interactions between cardiac output and portal venous and hepatic arterial flows","volume":"16","author":"Henderson","year":"1992","journal-title":"Hepatology"},{"key":"2021113011020628000_B12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/hep.510300112","article-title":"Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study","volume":"30","author":"Piscaglia","year":"1999","journal-title":"Hepatology"},{"key":"2021113011020628000_B13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/hep.1840170302","article-title":"Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis","volume":"17","author":"Navasa","year":"1993","journal-title":"Hepatology"},{"key":"2021113011020628000_B14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jhep.2012.03.007","article-title":"Functional aspects on the pathophysiology of portal hypertension in cirrhosis","volume":"57","author":"Garc\u00eda-Pag\u00e1n","year":"2012","journal-title":"J. Hepatol."},{"key":"2021113011020628000_B15","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments","volume":"62","author":"Bosch","year":"2015","journal-title":"J. Hepatol."},{"key":"2021113011020628000_B16","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1016\/j.transproceed.2011.08.113","article-title":"Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation","volume":"43","author":"Xie","year":"2011","journal-title":"Transplant. Proc."},{"key":"2021113011020628000_B17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1499-3872(11)60124-0","article-title":"Changes of gut bacteria and immune parameters in liver transplant recipients","volume":"11","author":"Wu","year":"2012","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"2021113011020628000_B18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/hep.28535","article-title":"Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection: El-Serag et al","volume":"64","author":"El-Serag","year":"2016","journal-title":"Hepatology"},{"key":"2021113011020628000_B19","article-title":"Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication","author":"van der Meer","year":"2016","journal-title":"J. Hepatol."},{"key":"2021113011020628000_B20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cgh.2008.02.012","article-title":"Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients","volume":"6","author":"Ohki","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2021113011020628000_B21","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cgh.2006.05.013","article-title":"Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis","volume":"4","author":"N\u2019Kontchou","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2021113011020628000_B22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1053\/j.gastro.2015.03.044","article-title":"Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma","volume":"149","author":"Hassan","year":"2015","journal-title":"Gastroenterology"},{"key":"2021113011020628000_B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-018-1502-7","article-title":"Benign and malignant hepatocellular lesions in patients with vascular liver diseases","author":"Vilgrain","year":"2018","journal-title":"Abdom. Radiol."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/132\/12\/1341\/449870\/cs-2018-0129c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/132\/12\/1341\/449870\/cs-2018-0129c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:56:43Z","timestamp":1638273403000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/132\/12\/1341\/72082\/Cirrhosis-regression-extrahepatic-angiogenesis-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,28]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,6,29]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20180129","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,28]]}}}